Compare Beyfortus vs. Abrysvo
Head-to-head comparisons of medication uses, side effects, warnings, and more.
- Beyfortus (nirsevimab)Abrysvo (RSV vaccine)
- Beyfortus (nirsevimab)Abrysvo (RSV vaccine)
Summary of Beyfortus vs. Abrysvo
Summary for Monoclonal antibodyPrescription onlyBeyfortus (nirsevimab or nirsevimab-alip) is an injection given to babies and children up to 24 months old. It's used to prevent them from getting very sick from respiratory syncytial virus (RSV). It's not an RSV vaccine. Instead, it's a monoclonal antibody that gives protection against the virus for a short time. Beyfortus (nirsevimab) is now part of the CDC Child Immunization Schedule. The usual dosage is 1 to 2 injections into the muscle during or at the start of the RSV season. It's well-tolerated with only a few side effects.
Summary for VaccinePrescription onlyAbrysvo (RSV vaccine) is a vaccine that helps lower your risk of getting serious lung infections caused by respiratory syncytial virus (RSV). It's FDA approved for adults 60 years and older, and adults 18 to 59 years who have a higher risk of getting seriously ill from RSV. It's also approved for pregnant mothers between 32 and 36 weeks gestation to help protect their babies from RSV after birth. Abrysvo (RSV vaccine) is given as a single injection into the muscle. Common side effects include tiredness, headache, and injection site reactions like pain, swelling, or redness.
Indications of Beyfortus vs. Abrysvo
Indications for•Prevention of respiratory syncytial virus (RSV) in young children of certain ages•Newborns and infants born during or entering their first RSV season•Children up to 24 months old at risk of severe RSV illness through their second RSV seasonIndications forPrevention of serious lung infections caused by respiratory syncytial virus (RSV) in:
•Adults 60 years and older•Adults 18 to 59 years old who have a higher risk of illness due to RSV•Pregnant mothers between 32 to 36 weeks gestationPros and Cons of Beyfortus vs. Abrysvo
Pros and Const for Monoclonal antibodyPros•Given during one medical visit•Can lower the risk of severe RSV-related illness by about 70% in full-term and premature babies•Not many side effectsCons•Injection can be uncomfortable•Protection might only last for about 5 months•Not known if it's safe or if it works well for children older than 24 monthsPros and Const for VaccinePros•Only need one dose•Protects both adults and newborns from serious RSV illness•Can be given with other vaccinesCons•Injection might be uncomfortable•Not approved for people under 18 years old•Common side effects include tiredness and headacheCommon Side Effects of Beyfortus vs. Abrysvo
Common Side Effects for•Side effects aren't common. See Other Side Effects.Common Side Effects for18 to 59 years old:
•Tiredness (37%)•Pain at injection site (35%)•Headache (28%)•Muscle pain (24%)•Diarrhea (15%)•Joint pain (12%)•Nausea (12%)60 years and older:
•Tiredness (16%)•Headache (13%)•Pain at injection site (11%)•Muscle pain (10%)Pregnant mothers:
•Tiredness (46%)•Pain at injection site (41%)•Headache (31%)•Muscle pain (27%)•Nausea (20%)Warnings of Beyfortus vs. Abrysvo
Common Side Effects for•Severe allergic reaction•Caution use in children with bleeding problemsCommon Side Effects for•Guillain‑Barré syndrome•Potential risk of preterm (early) birth•Severe allergic reaction•Fainting•Weaker vaccine protectionPrices with our coupons for Beyfortus vs. Abrysvo
Browse medications
View AllResearch prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.